HRT litigation « Lawyers USA Online

Pa. court reinstates $28M punitive award in HRT case

Published: January 10, 2012

Tags: breast cancer, HRT litigation, Premarin, Prempro, product liability, Provera, Upjohn, Wyeth

A $28 million award of punitive damages was not unconstitutionally excessive in a product liability case brought by a woman who contracted breast cancer after taking hormone replacement therapy drugs, a Pennsylvania appellate court has ruled in reversing judgment.

Wyeth’s marketing efforts admissible in Prempro case

Published: January 10, 2012

Tags: breast cancer, HRT litigation, Prempro, product liability, Wyeth

Evidence of Wyeth’s marketing campaign for “off-label” Prempro uses was admissible in a product liability case brought by a woman who contracted breast cancer after taking the drug, a Pennsylvania appellate court has ruled.

Small firm turns the tide on Prempro litigation

By: Sylvia Hsieh
Published: January 18, 2011

Tags: breast cancer, hormone replacement therapy, hormone replacement therapy litigation, HRT litigation, Prempro, Wyeth, Wyeth Pharmaceuticals

In the ongoing mass tort over the hormone replacement therapy drug Prempro, two small firms recently teamed up to break the defense winning streak in the trials.

U.S. Supreme Court allows HRT suits to proceed

By: Kimberly Atkins
Published: October 14, 2010

Tags: HRT litigation, jurisdiction, Supreme Court

WASHINGTON – The U.S. Supreme Court rejected an appeal by several drug makers seeking to halt lawsuits brought by dozens of women who claim their hormone replacement therapy treatments caused breast cancer.